Androgenic alopecia. Androgenic alopecia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Females in the pre-menopausal period complaining of hair loss Patient consent to participate and fill out the informed consent form.
Exclusion criteria
Exclusion criteria: History of allergic response/hypersensitivity to any ingredients and pharmaceutical products. History of thyroid disorder, diabetes mellitus, polycystic ovary syndrome Subjects under medical treatment for hair problems, consuming drugs (such as minoxidil, finasteride, platelet rich plasma or Biotin) and laser therapy in the 2 months prior to the study Subjects under medical treatment for hair problems with 5 a-reductase inhibitors. Subjects under medical treatment with antiandrogenic agents (such as spironolactone, cimetidine and cyproterone acetate) in the 2 months prior to the study Subjects consuming systemic corticosteroid therapy for more than 14 days in the 2 months prior to the study Any active scalp disease in the 6 months prior to the study Any history of cancer or autoimmune diseases History of hair transplant Pregnancy or Brest - feeding History of serious acute illness in the 2 months prior to the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair count (number of hairs in 0.7 cm2). Timepoint: Week 8, week 16. Method of measurement: Trichoscan method.;Hair density (number of hairs in cm2). Timepoint: Week 8, week 16. Method of measurement: Trichoscan method.;Hair diameter. Timepoint: Week 8, week 16. Method of measurement: Trichoscan method.;Ratio of anagen to telogen. Timepoint: week8, week16. Method of measurement: Trichoscan method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Dandruff. Timepoint: Before and after study (week1, week16). Method of measurement: Patient view assessment (5 Likert).;Greasy hair. Timepoint: Before and after study (week1, week16). Method of measurement: Patient view assessment(5 Likert). | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences